Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,696 | -66,160 | -79,293 | -94,465 | -109,388 |
| Depreciation Amortization | 4,634 | 5,014 | 6,243 | 6,649 | 5,803 |
| Accounts receivable | -1,738 | -660 | 76 | 1,735 | -4,216 |
| Accounts payable and accrued liabilities | -716 | 3,891 | -1,271 | -1,754 | -4,773 |
| Other Working Capital | -31,394 | -772 | 33,664 | -6 | -11,999 |
| Other Operating Activity | 13,021 | 7,219 | 10,748 | 11,019 | 21,599 |
| Operating Cash Flow | $-47,889 | $-51,468 | $-29,833 | $-76,822 | $-102,974 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,079 | 21,173 | -32,208 | 63,495 | 15,730 |
| PPE Investments | -2,973 | -1,609 | -909 | -1,703 | -9,284 |
| Other Investing Activity | -4,500 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $8,606 | $19,564 | $-33,117 | $61,792 | $6,446 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 19,766 | N/A | N/A |
| Common Stock Issued | 36,463 | 41,991 | 23,006 | 2,705 | 7,743 |
| Financing Cash Flow | $36,463 | $41,991 | $42,772 | $2,705 | $7,743 |
| Beginning Cash Position | 36,449 | 26,362 | 46,540 | 58,865 | 147,650 |
| End Cash Position | 33,629 | 36,449 | 26,362 | 46,540 | 58,865 |
| Net Cash Flow | $-2,820 | $10,087 | $-20,178 | $-12,325 | $-88,785 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,889 | -51,468 | -29,833 | -76,822 | -102,974 |
| Capital Expenditure | -3,009 | -1,609 | -909 | -1,703 | -9,284 |
| Free Cash Flow | -50,898 | -53,077 | -30,742 | -78,525 | -112,258 |